Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma

Authors: Michelle MS Chew, Sook-Yee Gan, Alan SB Khoo, Eng-Lai Tan

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Nasopharyngeal carcinoma (NPC) is a type of neoplasm that is highly prevalent in East Asia and Africa with Epstein-Barr virus (EBV), genetic, and dietary factors implicated as possible aetiologic factors. Previous studies suggested the association of certain cytokines with the invasion and metastatic properties of NPC. The present study examined the roles of EBV latent membrane protein-1 (LMP1), interleukin-6 (IL-6), interleukin-10 (IL-10), transforming growth factor-beta 1 (TGF-β1) and laminin in the regulation of matrix-metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) in NPC. The effects of these factors on bmi-1, an oncogene, and ngx6, a tumour suppressor gene, were also investigated.

Methods

TW01 cells expressing LMP1 (TW01-LMP1) were established via transfection with the B95.8 EBV LMP1 gene. Both TW01 and TW01-LMP1 cells were treated with 100 pg/ml IL-6, 1000 pg/ml IL-10 and 100 pg/ml TGF-β1, separately and also in combination at their respective concentration for 48 hours. Treated cells were subjected to laminin adherence assay. The cells were also cultured with and without laminin and assayed for MMP-3, MMP-9 and VEGF production using enzyme-linked immunosorbent assay (ELISA). The cellular apoptotic property was analysed using caspase-3 apoptosis assay. The expression of bmi-1 and ngx6 gene was investigated using real time reverse transcriptase polymerase chain reaction.

Results

LMP1 was found to reduce the adherence of NPC cells towards laminin (p < 0.05) as compared to control. Treatment with IL-6 at 100 pg/ml enhanced the production of MMP-9 in both TW01 and TW01-LMP1 cells (p < 0.05). When cultured on laminin, the levels of MMP-3 and VEGF were significantly increased (p < 0.05) in TW01-LMP1 cells. TW01-LMP1 cells had relatively greater resistance to apoptosis as compared to TW01 cells (p < 0.05). Laminin, IL-6 and LMP1 were found to up-regulate the expression of bmi-1 and suppressed the expression of ngx6.

Conclusions

We conclude that IL-6 reduced cell adherence towards laminin and increased MMP-9 production in NPC cells. Our data suggested that EBV LMP1 was able to confer resistance of apoptosis and increased MMP-9 production in NPC cells. When cultured on laminin, TW01 cells expressing the EBV LMP1 (TW0-LMP1) that were treated with IL-6 at 100 pg/ml displayed increased MMP-9 production, up-regulation of bmi-1 oncogene expression and down-regulation of ngx6 tumour suppressor gene expression. These findings implicate the roles of EBV LMP1, laminin and IL-6 in the promotion of invasion and metastasis in NPC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12 (6): 421-9. 10.1016/S1044579X02000858.CrossRefPubMed Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12 (6): 421-9. 10.1016/S1044579X02000858.CrossRefPubMed
2.
go back to reference Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol. 2000, 29 (6): 991-8. 10.1093/ije/29.6.991.CrossRefPubMed Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol. 2000, 29 (6): 991-8. 10.1093/ije/29.6.991.CrossRefPubMed
3.
go back to reference Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M: Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer. 2000, 89 (4): 715-23. 10.1002/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO;2-9.CrossRefPubMed Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M: Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer. 2000, 89 (4): 715-23. 10.1002/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO;2-9.CrossRefPubMed
4.
go back to reference Raab-Traub N: Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002, 12 (6): 431-41. 10.1016/S1044579X0200086X.CrossRefPubMed Raab-Traub N: Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002, 12 (6): 431-41. 10.1016/S1044579X0200086X.CrossRefPubMed
5.
go back to reference Lee DC, Chua DT, Wei WI, Sham JS, Lau AS: Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma. Biomed Pharmacother. 2007, 61 (9): 520-6. 10.1016/j.biopha.2007.08.007.CrossRefPubMed Lee DC, Chua DT, Wei WI, Sham JS, Lau AS: Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma. Biomed Pharmacother. 2007, 61 (9): 520-6. 10.1016/j.biopha.2007.08.007.CrossRefPubMed
6.
go back to reference Givant-Horwitz V, Davidson B, Reich R: Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223 (1): 1-10. 10.1016/j.canlet.2004.08.030.CrossRefPubMed Givant-Horwitz V, Davidson B, Reich R: Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223 (1): 1-10. 10.1016/j.canlet.2004.08.030.CrossRefPubMed
7.
8.
go back to reference McCawley LJ, Wright J, LaFleur BJ, Crawford HC, Matrisian LM: Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment. Am J Pathol. 2008, 173 (5): 1528-39. 10.2353/ajpath.2008.080132.CrossRefPubMedPubMedCentral McCawley LJ, Wright J, LaFleur BJ, Crawford HC, Matrisian LM: Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment. Am J Pathol. 2008, 173 (5): 1528-39. 10.2353/ajpath.2008.080132.CrossRefPubMedPubMedCentral
9.
go back to reference Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G: Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006, 72 (11): 1605-21. 10.1016/j.bcp.2006.06.029.CrossRefPubMed Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G: Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006, 72 (11): 1605-21. 10.1016/j.bcp.2006.06.029.CrossRefPubMed
10.
go back to reference Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, et al: Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res. 2001, 7 (7): 1946-51.PubMed Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, et al: Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res. 2001, 7 (7): 1946-51.PubMed
11.
go back to reference Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T: Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol. 2001, 159 (1): 27-33.CrossRefPubMedPubMedCentral Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T: Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol. 2001, 159 (1): 27-33.CrossRefPubMedPubMedCentral
12.
go back to reference Rakoff-Nahoum S: Why cancer and inflammation?. Yale J Biol Med. 2006, 79 (3-4): 123-30.PubMed Rakoff-Nahoum S: Why cancer and inflammation?. Yale J Biol Med. 2006, 79 (3-4): 123-30.PubMed
13.
go back to reference Lu H, Ouyang W, Huang C: Inflammation, a key event in cancer development. Mol Cancer Res. 2006, 4 (4): 221-33. 10.1158/1541-7786.MCR-05-0261.CrossRefPubMed Lu H, Ouyang W, Huang C: Inflammation, a key event in cancer development. Mol Cancer Res. 2006, 4 (4): 221-33. 10.1158/1541-7786.MCR-05-0261.CrossRefPubMed
14.
go back to reference Tan EL, Selvaratnam G, Kananathan R, Sam CK: Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer. 2006, 6: 227-10.1186/1471-2407-6-227.CrossRefPubMedPubMedCentral Tan EL, Selvaratnam G, Kananathan R, Sam CK: Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer. 2006, 6: 227-10.1186/1471-2407-6-227.CrossRefPubMedPubMedCentral
15.
go back to reference Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC: Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate. 2000, 42 (3): 239-42. 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G.CrossRefPubMed Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC: Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate. 2000, 42 (3): 239-42. 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G.CrossRefPubMed
16.
go back to reference Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM: The dual role of IL-10. Trends Immunol. 2003, 24 (1): 36-43. 10.1016/S1471-4906(02)00009-1.CrossRefPubMed Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM: The dual role of IL-10. Trends Immunol. 2003, 24 (1): 36-43. 10.1016/S1471-4906(02)00009-1.CrossRefPubMed
17.
go back to reference Dumont N, Arteaga CL: Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res. 2000, 2 (2): 125-32. 10.1186/bcr44.CrossRefPubMedPubMedCentral Dumont N, Arteaga CL: Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res. 2000, 2 (2): 125-32. 10.1186/bcr44.CrossRefPubMedPubMedCentral
18.
go back to reference Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, et al: Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest. 1990, 62 (6): 713-24.PubMed Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, et al: Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest. 1990, 62 (6): 713-24.PubMed
19.
go back to reference Tan EL, Sam CK: Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy. Exp Oncol. 2007, 29 (3): 166-74.PubMed Tan EL, Sam CK: Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy. Exp Oncol. 2007, 29 (3): 166-74.PubMed
20.
go back to reference Johansson P, Jansson A, Ruetschi U, Rymo L: The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene. J Virol. 2010, 84 (6): 2787-97. 10.1128/JVI.01052-09.CrossRefPubMedPubMedCentral Johansson P, Jansson A, Ruetschi U, Rymo L: The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene. J Virol. 2010, 84 (6): 2787-97. 10.1128/JVI.01052-09.CrossRefPubMedPubMedCentral
21.
go back to reference Wang C, Ai M, Ren W, Xiao H, Li X, Tang F, et al: Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. Chin Med J (Engl). 2003, 116 (7): 1022-8. Wang C, Ai M, Ren W, Xiao H, Li X, Tang F, et al: Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. Chin Med J (Engl). 2003, 116 (7): 1022-8.
22.
go back to reference Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I: Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways. Biochem Biophys Res Commun. 2007, 360 (1): 263-8. 10.1016/j.bbrc.2007.06.043.CrossRefPubMed Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I: Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways. Biochem Biophys Res Commun. 2007, 360 (1): 263-8. 10.1016/j.bbrc.2007.06.043.CrossRefPubMed
23.
go back to reference Lam N, Sugden B: CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal. 2003, 15 (1): 9-16. 10.1016/S0898-6568(02)00083-9.CrossRefPubMed Lam N, Sugden B: CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal. 2003, 15 (1): 9-16. 10.1016/S0898-6568(02)00083-9.CrossRefPubMed
24.
go back to reference Shao JY, Ernberg I, Biberfeld P, Heiden T, Zeng YX, Hu LF: Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma. Anticancer Res. 2004, 24 (4): 2309-18.PubMed Shao JY, Ernberg I, Biberfeld P, Heiden T, Zeng YX, Hu LF: Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma. Anticancer Res. 2004, 24 (4): 2309-18.PubMed
25.
go back to reference Qian CN, Zhang CQ, Guo X, Hong MH, Cao SM, Mai WY, et al: Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer. 2000, 88 (2): 255-61. 10.1002/(SICI)1097-0142(20000115)88:2<255::AID-CNCR2>3.0.CO;2-N.CrossRefPubMed Qian CN, Zhang CQ, Guo X, Hong MH, Cao SM, Mai WY, et al: Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer. 2000, 88 (2): 255-61. 10.1002/(SICI)1097-0142(20000115)88:2<255::AID-CNCR2>3.0.CO;2-N.CrossRefPubMed
26.
go back to reference Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002, 29 (6 Suppl 16): 15-8.CrossRefPubMed Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002, 29 (6 Suppl 16): 15-8.CrossRefPubMed
27.
go back to reference Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, et al: The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope. 2000, 110 (12): 2066-9. 10.1097/00005537-200012000-00017.CrossRefPubMed Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, et al: The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope. 2000, 110 (12): 2066-9. 10.1097/00005537-200012000-00017.CrossRefPubMed
28.
go back to reference Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M: Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 1999, 5 (4): 775-82.PubMed Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M: Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 1999, 5 (4): 775-82.PubMed
29.
go back to reference Chang SH, Chang HC, Hung WC: Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells. Oral Oncol. 2008, 44 (9): 891-7. 10.1016/j.oraloncology.2007.11.005.CrossRefPubMed Chang SH, Chang HC, Hung WC: Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells. Oral Oncol. 2008, 44 (9): 891-7. 10.1016/j.oraloncology.2007.11.005.CrossRefPubMed
30.
go back to reference Fries KL, Miller WE, Raab-Traub N: Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol. 1996, 70 (12): 8653-9.PubMedPubMedCentral Fries KL, Miller WE, Raab-Traub N: Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol. 1996, 70 (12): 8653-9.PubMedPubMedCentral
31.
go back to reference Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM: The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem. 1992, 267 (34): 24157-60.PubMed Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM: The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem. 1992, 267 (34): 24157-60.PubMed
32.
go back to reference Grinstein E, Wernet P: Cellular signaling in normal and cancerous stem cells. Cell Signal. 2007, 19 (12): 2428-33. 10.1016/j.cellsig.2007.06.021.CrossRefPubMed Grinstein E, Wernet P: Cellular signaling in normal and cancerous stem cells. Cell Signal. 2007, 19 (12): 2428-33. 10.1016/j.cellsig.2007.06.021.CrossRefPubMed
33.
go back to reference Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 1999, 397 (6715): 164-8. 10.1038/16476.CrossRefPubMed Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 1999, 397 (6715): 164-8. 10.1038/16476.CrossRefPubMed
35.
go back to reference Ma J, Zhou J, Fan S, Wang L, Li X, Yan Q, et al: Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis. 2005, 26 (2): 281-91. 10.1093/carcin/bgh312.CrossRefPubMed Ma J, Zhou J, Fan S, Wang L, Li X, Yan Q, et al: Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis. 2005, 26 (2): 281-91. 10.1093/carcin/bgh312.CrossRefPubMed
Metadata
Title
Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma
Authors
Michelle MS Chew
Sook-Yee Gan
Alan SB Khoo
Eng-Lai Tan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-574

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine